These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1816185

  • 21. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production.
    Sultan N, Cirak MY, Erbaş D.
    Microbios; 2000; 103(405):97-106. PubMed ID: 11092191
    [Abstract] [Full Text] [Related]

  • 22. Cefodizime: effects of sub-inhibitory concentrations on adhesiveness and bacterial morphology of Staphylococcus aureus and Escherichia coli: comparison with cefotaxime and ceftriaxone.
    Braga PC, Dal Sasso M, Maci S.
    J Antimicrob Chemother; 1997 Jan; 39(1):79-84. PubMed ID: 9044031
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S, Nagayama A.
    Chemotherapy; 1995 Jan; 41(3):178-86. PubMed ID: 7656663
    [Abstract] [Full Text] [Related]

  • 28. Interaction of cefotaxime versus desacetyl cefotaxime on human neutrophil functions.
    Labro M, Bryskier A.
    Chemioterapia; 1987 Jun; 6(2 Suppl):237-9. PubMed ID: 3334564
    [No Abstract] [Full Text] [Related]

  • 29. Comparative study of the effects of cefodizime and HBW 538 in potentiating the production of reactive oxygen species by human polymorphonuclear leukocytes.
    Ono Y, Kunii O, Ohyatsu I, Tokumura Y, Miyashita T, Aoki M, Sugiyama H, Nishiya H, Miyashita H, Goldstein E.
    Chemotherapy; 1994 Jun; 40(6):404-11. PubMed ID: 7842824
    [Abstract] [Full Text] [Related]

  • 30. Effect of ciprofloxacin on phagocytosis.
    Forsgren A, Bergkvist PI.
    Eur J Clin Microbiol; 1985 Dec; 4(6):575-8. PubMed ID: 2936604
    [Abstract] [Full Text] [Related]

  • 31. In vitro effect of amikacin, imipenem, cefodizime, IFNalpha-2a alone and combinations of antibiotics with IFNalpha-2a on polymorphonuclear leukocyte function in chronic hepatitis patients.
    Adalati R, Gürer US, Cevikbaş A, Johansson C.
    Chemotherapy; 2001 Dec; 47(4):261-5. PubMed ID: 11399862
    [Abstract] [Full Text] [Related]

  • 32. In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime.
    Fietta A, Bersani C, Bertoletti R, Grassi FM, Grassi GG.
    Chemotherapy; 1988 Dec; 34(5):430-6. PubMed ID: 3053065
    [Abstract] [Full Text] [Related]

  • 33. Phagocytic and bactericidal activity of blood and milk-resident neutrophils against Staphylococcus aureus in primiparous and multiparous cows during early lactation.
    Mehrzad J, Duchateau L, Burvenich C.
    Vet Microbiol; 2009 Feb 16; 134(1-2):106-12. PubMed ID: 18954946
    [Abstract] [Full Text] [Related]

  • 34. In-vitro effects of cefodizime on leucocyte functions and colony formation from granulocyte-monocyte progenitors.
    Shin WS, Min CK, Kim YR, Yoo JH, Kang MW.
    J Antimicrob Chemother; 1996 Jan 16; 37(1):93-103. PubMed ID: 8647779
    [Abstract] [Full Text] [Related]

  • 35. Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agents.
    Pérez Fernández P, Herrera I, Martínez P, Gómez-Lus ML, Prieto J.
    Chemotherapy; 1995 Jan 16; 41(1):45-9. PubMed ID: 7875021
    [Abstract] [Full Text] [Related]

  • 36. Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes.
    van Asbeck BS, Marx JJ, Struyvenberg A, van Kats JH, Verhoef J.
    J Immunol; 1984 Feb 16; 132(2):851-6. PubMed ID: 6690620
    [Abstract] [Full Text] [Related]

  • 37. The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure. In vitro and ex vivo studies.
    McCafferty AC, McGregor E, Jones M, Henderson IS, Cree IA.
    Int J Clin Lab Res; 1996 Feb 16; 26(4):229-35. PubMed ID: 9007612
    [Abstract] [Full Text] [Related]

  • 38. Effects of beta-lactam antibiotics imipenem/cilastatin and cefodizime on cellular and humoral immune responses in BALB/c-mice.
    Grochla I, Ko HL, Beuth J, Roszkowski K, Roszkowski W, Pulverer G.
    Zentralbl Bakteriol; 1990 Nov 16; 274(2):250-8. PubMed ID: 2085374
    [Abstract] [Full Text] [Related]

  • 39. [Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. I. Synergistic action with minocycline].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R.
    Jpn J Antibiot; 1991 Dec 16; 44(12):1386-91. PubMed ID: 1798073
    [Abstract] [Full Text] [Related]

  • 40. Monitoring of polymorphonuclear leukocyte functions in diabetes mellitus--a comparative study of conventional radiometric function tests and low-light imaging systems.
    Marhoffer W, Stein M, Schleinkofer L, Federlin K.
    J Biolumin Chemilumin; 1994 Dec 16; 9(3):165-70. PubMed ID: 7942121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.